Impact of COVID-19 Outbreak on Anti-Emetic Drug, Global Market Research Report 2020
This report also analyses the impact of Coronavirus COVID-19 on the Anti-Emetic Drug industry.
Based on our recent survey, we have several different scenarios about the Anti-Emetic Drug YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Anti-Emetic Drug will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Anti-Emetic Drug market is segmented into
The Anti-Emetic Drug market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Anti-Emetic Drug market report are:
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Anti-Emetic Drug market include:
Based on our recent survey, we have several different scenarios about the Anti-Emetic Drug YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Anti-Emetic Drug will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Anti-Emetic Drug market is segmented into
- Oral
- Injection
- Others
- Hospital
- Clinic
- Home Care
- Others
The Anti-Emetic Drug market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Anti-Emetic Drug market report are:
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Anti-Emetic Drug market include:
- Merck
- Novartis
- Glenmark Pharmaceuticals
- F. Hoffmann-La Roche
- Heron Therapeutics
- Kyowa Kirin
- Aurobindo Pharma
- Mylan
- Hikma
- Akorn
- Dr. Reddy’s Laboratories
- Cipla
- Fresenius Kabi
- Wockhardt
- Sun Pharmaceutical Industries
- Teva Pharmaceutical
- Pfizer
1 ANTI-EMETIC DRUG MARKET OVERVIEW
1.1 Product Overview and Scope of Anti-Emetic Drug
1.2 Covid-19 Implications on Anti-Emetic Drug Segment by Type
1.2.1 Global Anti-Emetic Drug Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Oral
1.2.3 Injection
1.2.4 Others
1.3 Covid-19 Implications on Anti-Emetic Drug Segment by Application
1.3.1 Anti-Emetic Drug Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.3.5 Others
1.4 Covid-19 Implications on Global Anti-Emetic Drug Market Size Estimates and Forecasts
1.4.1 Global Anti-Emetic Drug Revenue 2015-2026
1.4.2 Global Anti-Emetic Drug Sales 2015-2026
1.4.3 Anti-Emetic Drug Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19): Anti-Emetic Drug Industry Impact
1.5.1 How the Covid-19 is Affecting the Anti-Emetic Drug Industry
1.5.1.1 Anti-Emetic Drug Business Impact Assessment - Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Anti-Emetic Drug Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Anti-Emetic Drug Players to Combat Covid-19 Impact
2 COVID-19 IMPLICATIONS ON GLOBAL ANTI-EMETIC DRUG MARKET COMPETITION BY MANUFACTURERS
2.1 Global Anti-Emetic Drug Sales Market Share by Manufacturers (2015-2020)
2.2 Global Anti-Emetic Drug Revenue Share by Manufacturers (2015-2020)
2.3 Global Anti-Emetic Drug Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Anti-Emetic Drug Manufacturing Sites, Area Served, Product Type
2.5 Anti-Emetic Drug Market Competitive Situation and Trends
2.5.1 Anti-Emetic Drug Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Anti-Emetic Drug Players (Opinion Leaders)
3 COVID-19 IMPLICATIONS ON ANTI-EMETIC DRUG RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Anti-Emetic Drug Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Anti-Emetic Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Anti-Emetic Drug Market Facts & Figures by Country
3.3.1 North America Anti-Emetic Drug Sales by Country
3.3.2 North America Anti-Emetic Drug Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Anti-Emetic Drug Market Facts & Figures by Country
3.4.1 Europe Anti-Emetic Drug Sales by Country
3.4.2 Europe Anti-Emetic Drug Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-Emetic Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-Emetic Drug Sales by Region
3.5.2 Asia Pacific Anti-Emetic Drug Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anti-Emetic Drug Market Facts & Figures by Country
3.6.1 Latin America Anti-Emetic Drug Sales by Country
3.6.2 Latin America Anti-Emetic Drug Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Anti-Emetic Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-Emetic Drug Sales by Country
3.7.2 Middle East and Africa Anti-Emetic Drug Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 GLOBAL ANTI-EMETIC DRUG HISTORIC MARKET ANALYSIS BY TYPE
4.1 Global Anti-Emetic Drug Sales Market Share by Type (2015-2020)
4.2 Global Anti-Emetic Drug Revenue Market Share by Type (2015-2020)
4.3 Global Anti-Emetic Drug Price Market Share by Type (2015-2020)
4.4 Global Anti-Emetic Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 GLOBAL ANTI-EMETIC DRUG HISTORIC MARKET ANALYSIS BY APPLICATION
5.1 Global Anti-Emetic Drug Sales Market Share by Application (2015-2020)
5.2 Global Anti-Emetic Drug Revenue Market Share by Application (2015-2020)
5.3 Global Anti-Emetic Drug Price by Application (2015-2020)
6 COMPANY PROFILES AND KEY FIGURES IN ANTI-EMETIC DRUG BUSINESS
6.1 Merck
6.1.1 Corporation Information
6.1.2 Merck Description, Business Overview and Total Revenue
6.1.3 Merck Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Merck Products Offered
6.1.5 Merck Recent Development
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description, Business Overview and Total Revenue
6.2.3 Novartis Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Novartis Products Offered
6.2.5 Novartis Recent Development
6.3 Glenmark Pharmaceuticals
6.3.1 Glenmark Pharmaceuticals Corporation Information
6.3.2 Glenmark Pharmaceuticals Description, Business Overview and Total Revenue
6.3.3 Glenmark Pharmaceuticals Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Glenmark Pharmaceuticals Products Offered
6.3.5 Glenmark Pharmaceuticals Recent Development
6.4 F. Hoffmann-La Roche
6.4.1 F. Hoffmann-La Roche Corporation Information
6.4.2 F. Hoffmann-La Roche Description, Business Overview and Total Revenue
6.4.3 F. Hoffmann-La Roche Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 F. Hoffmann-La Roche Products Offered
6.4.5 F. Hoffmann-La Roche Recent Development
6.5 Heron Therapeutics
6.5.1 Heron Therapeutics Corporation Information
6.5.2 Heron Therapeutics Description, Business Overview and Total Revenue
6.5.3 Heron Therapeutics Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Heron Therapeutics Products Offered
6.5.5 Heron Therapeutics Recent Development
6.6 Kyowa Kirin
6.6.1 Kyowa Kirin Corporation Information
6.6.2 Kyowa Kirin Description, Business Overview and Total Revenue
6.6.3 Kyowa Kirin Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Kyowa Kirin Products Offered
6.6.5 Kyowa Kirin Recent Development
6.7 Aurobindo Pharma
6.6.1 Aurobindo Pharma Corporation Information
6.6.2 Aurobindo Pharma Description, Business Overview and Total Revenue
6.6.3 Aurobindo Pharma Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Aurobindo Pharma Products Offered
6.7.5 Aurobindo Pharma Recent Development
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description, Business Overview and Total Revenue
6.8.3 Mylan Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Mylan Products Offered
6.8.5 Mylan Recent Development
6.9 Hikma
6.9.1 Hikma Corporation Information
6.9.2 Hikma Description, Business Overview and Total Revenue
6.9.3 Hikma Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Hikma Products Offered
6.9.5 Hikma Recent Development
6.10 Akorn
6.10.1 Akorn Corporation Information
6.10.2 Akorn Description, Business Overview and Total Revenue
6.10.3 Akorn Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Akorn Products Offered
6.10.5 Akorn Recent Development
6.11 Dr. Reddy’s Laboratories
6.11.1 Dr. Reddy’s Laboratories Corporation Information
6.11.2 Dr. Reddy’s Laboratories Anti-Emetic Drug Description, Business Overview and Total Revenue
6.11.3 Dr. Reddy’s Laboratories Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Dr. Reddy’s Laboratories Products Offered
6.11.5 Dr. Reddy’s Laboratories Recent Development
6.12 Cipla
6.12.1 Cipla Corporation Information
6.12.2 Cipla Anti-Emetic Drug Description, Business Overview and Total Revenue
6.12.3 Cipla Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Cipla Products Offered
6.12.5 Cipla Recent Development
6.13 Fresenius Kabi
6.13.1 Fresenius Kabi Corporation Information
6.13.2 Fresenius Kabi Anti-Emetic Drug Description, Business Overview and Total Revenue
6.13.3 Fresenius Kabi Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Fresenius Kabi Products Offered
6.13.5 Fresenius Kabi Recent Development
6.14 Wockhardt
6.14.1 Wockhardt Corporation Information
6.14.2 Wockhardt Anti-Emetic Drug Description, Business Overview and Total Revenue
6.14.3 Wockhardt Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Wockhardt Products Offered
6.14.5 Wockhardt Recent Development
6.15 Sun Pharmaceutical Industries
6.15.1 Sun Pharmaceutical Industries Corporation Information
6.15.2 Sun Pharmaceutical Industries Anti-Emetic Drug Description, Business Overview and Total Revenue
6.15.3 Sun Pharmaceutical Industries Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Sun Pharmaceutical Industries Products Offered
6.15.5 Sun Pharmaceutical Industries Recent Development
6.16 Teva Pharmaceutical
6.16.1 Teva Pharmaceutical Corporation Information
6.16.2 Teva Pharmaceutical Anti-Emetic Drug Description, Business Overview and Total Revenue
6.16.3 Teva Pharmaceutical Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Teva Pharmaceutical Products Offered
6.16.5 Teva Pharmaceutical Recent Development
6.17 Pfizer
6.17.1 Pfizer Corporation Information
6.17.2 Pfizer Anti-Emetic Drug Description, Business Overview and Total Revenue
6.17.3 Pfizer Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Pfizer Products Offered
6.17.5 Pfizer Recent Development
7 ANTI-EMETIC DRUG MANUFACTURING COST ANALYSIS
7.1 Anti-Emetic Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-Emetic Drug
7.4 Anti-Emetic Drug Industrial Chain Analysis
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
8.1 Marketing Channel
8.2 Anti-Emetic Drug Distributors List
8.3 Anti-Emetic Drug Customers
9 MARKET DYNAMICS
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 GLOBAL MARKET FORECAST
10.1 Global Anti-Emetic Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-Emetic Drug by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Anti-Emetic Drug by Type (2021-2026)
10.2 Anti-Emetic Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-Emetic Drug by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Anti-Emetic Drug by Application (2021-2026)
10.3 Anti-Emetic Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-Emetic Drug by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Anti-Emetic Drug by Region (2021-2026)
10.4 North America Anti-Emetic Drug Estimates and Projections (2021-2026)
10.5 Europe Anti-Emetic Drug Estimates and Projections (2021-2026)
10.6 Asia Pacific Anti-Emetic Drug Estimates and Projections (2021-2026)
10.7 Latin America Anti-Emetic Drug Estimates and Projections (2021-2026)
10.8 Middle East and Africa Anti-Emetic Drug Estimates and Projections (2021-2026)
11 RESEARCH FINDING AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
1.1 Product Overview and Scope of Anti-Emetic Drug
1.2 Covid-19 Implications on Anti-Emetic Drug Segment by Type
1.2.1 Global Anti-Emetic Drug Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Oral
1.2.3 Injection
1.2.4 Others
1.3 Covid-19 Implications on Anti-Emetic Drug Segment by Application
1.3.1 Anti-Emetic Drug Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.3.5 Others
1.4 Covid-19 Implications on Global Anti-Emetic Drug Market Size Estimates and Forecasts
1.4.1 Global Anti-Emetic Drug Revenue 2015-2026
1.4.2 Global Anti-Emetic Drug Sales 2015-2026
1.4.3 Anti-Emetic Drug Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19): Anti-Emetic Drug Industry Impact
1.5.1 How the Covid-19 is Affecting the Anti-Emetic Drug Industry
1.5.1.1 Anti-Emetic Drug Business Impact Assessment - Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Anti-Emetic Drug Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Anti-Emetic Drug Players to Combat Covid-19 Impact
2 COVID-19 IMPLICATIONS ON GLOBAL ANTI-EMETIC DRUG MARKET COMPETITION BY MANUFACTURERS
2.1 Global Anti-Emetic Drug Sales Market Share by Manufacturers (2015-2020)
2.2 Global Anti-Emetic Drug Revenue Share by Manufacturers (2015-2020)
2.3 Global Anti-Emetic Drug Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Anti-Emetic Drug Manufacturing Sites, Area Served, Product Type
2.5 Anti-Emetic Drug Market Competitive Situation and Trends
2.5.1 Anti-Emetic Drug Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Anti-Emetic Drug Players (Opinion Leaders)
3 COVID-19 IMPLICATIONS ON ANTI-EMETIC DRUG RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Anti-Emetic Drug Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Anti-Emetic Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Anti-Emetic Drug Market Facts & Figures by Country
3.3.1 North America Anti-Emetic Drug Sales by Country
3.3.2 North America Anti-Emetic Drug Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Anti-Emetic Drug Market Facts & Figures by Country
3.4.1 Europe Anti-Emetic Drug Sales by Country
3.4.2 Europe Anti-Emetic Drug Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-Emetic Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-Emetic Drug Sales by Region
3.5.2 Asia Pacific Anti-Emetic Drug Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anti-Emetic Drug Market Facts & Figures by Country
3.6.1 Latin America Anti-Emetic Drug Sales by Country
3.6.2 Latin America Anti-Emetic Drug Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Anti-Emetic Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-Emetic Drug Sales by Country
3.7.2 Middle East and Africa Anti-Emetic Drug Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 GLOBAL ANTI-EMETIC DRUG HISTORIC MARKET ANALYSIS BY TYPE
4.1 Global Anti-Emetic Drug Sales Market Share by Type (2015-2020)
4.2 Global Anti-Emetic Drug Revenue Market Share by Type (2015-2020)
4.3 Global Anti-Emetic Drug Price Market Share by Type (2015-2020)
4.4 Global Anti-Emetic Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 GLOBAL ANTI-EMETIC DRUG HISTORIC MARKET ANALYSIS BY APPLICATION
5.1 Global Anti-Emetic Drug Sales Market Share by Application (2015-2020)
5.2 Global Anti-Emetic Drug Revenue Market Share by Application (2015-2020)
5.3 Global Anti-Emetic Drug Price by Application (2015-2020)
6 COMPANY PROFILES AND KEY FIGURES IN ANTI-EMETIC DRUG BUSINESS
6.1 Merck
6.1.1 Corporation Information
6.1.2 Merck Description, Business Overview and Total Revenue
6.1.3 Merck Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Merck Products Offered
6.1.5 Merck Recent Development
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description, Business Overview and Total Revenue
6.2.3 Novartis Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Novartis Products Offered
6.2.5 Novartis Recent Development
6.3 Glenmark Pharmaceuticals
6.3.1 Glenmark Pharmaceuticals Corporation Information
6.3.2 Glenmark Pharmaceuticals Description, Business Overview and Total Revenue
6.3.3 Glenmark Pharmaceuticals Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Glenmark Pharmaceuticals Products Offered
6.3.5 Glenmark Pharmaceuticals Recent Development
6.4 F. Hoffmann-La Roche
6.4.1 F. Hoffmann-La Roche Corporation Information
6.4.2 F. Hoffmann-La Roche Description, Business Overview and Total Revenue
6.4.3 F. Hoffmann-La Roche Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 F. Hoffmann-La Roche Products Offered
6.4.5 F. Hoffmann-La Roche Recent Development
6.5 Heron Therapeutics
6.5.1 Heron Therapeutics Corporation Information
6.5.2 Heron Therapeutics Description, Business Overview and Total Revenue
6.5.3 Heron Therapeutics Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Heron Therapeutics Products Offered
6.5.5 Heron Therapeutics Recent Development
6.6 Kyowa Kirin
6.6.1 Kyowa Kirin Corporation Information
6.6.2 Kyowa Kirin Description, Business Overview and Total Revenue
6.6.3 Kyowa Kirin Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Kyowa Kirin Products Offered
6.6.5 Kyowa Kirin Recent Development
6.7 Aurobindo Pharma
6.6.1 Aurobindo Pharma Corporation Information
6.6.2 Aurobindo Pharma Description, Business Overview and Total Revenue
6.6.3 Aurobindo Pharma Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Aurobindo Pharma Products Offered
6.7.5 Aurobindo Pharma Recent Development
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description, Business Overview and Total Revenue
6.8.3 Mylan Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Mylan Products Offered
6.8.5 Mylan Recent Development
6.9 Hikma
6.9.1 Hikma Corporation Information
6.9.2 Hikma Description, Business Overview and Total Revenue
6.9.3 Hikma Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Hikma Products Offered
6.9.5 Hikma Recent Development
6.10 Akorn
6.10.1 Akorn Corporation Information
6.10.2 Akorn Description, Business Overview and Total Revenue
6.10.3 Akorn Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Akorn Products Offered
6.10.5 Akorn Recent Development
6.11 Dr. Reddy’s Laboratories
6.11.1 Dr. Reddy’s Laboratories Corporation Information
6.11.2 Dr. Reddy’s Laboratories Anti-Emetic Drug Description, Business Overview and Total Revenue
6.11.3 Dr. Reddy’s Laboratories Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Dr. Reddy’s Laboratories Products Offered
6.11.5 Dr. Reddy’s Laboratories Recent Development
6.12 Cipla
6.12.1 Cipla Corporation Information
6.12.2 Cipla Anti-Emetic Drug Description, Business Overview and Total Revenue
6.12.3 Cipla Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Cipla Products Offered
6.12.5 Cipla Recent Development
6.13 Fresenius Kabi
6.13.1 Fresenius Kabi Corporation Information
6.13.2 Fresenius Kabi Anti-Emetic Drug Description, Business Overview and Total Revenue
6.13.3 Fresenius Kabi Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Fresenius Kabi Products Offered
6.13.5 Fresenius Kabi Recent Development
6.14 Wockhardt
6.14.1 Wockhardt Corporation Information
6.14.2 Wockhardt Anti-Emetic Drug Description, Business Overview and Total Revenue
6.14.3 Wockhardt Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Wockhardt Products Offered
6.14.5 Wockhardt Recent Development
6.15 Sun Pharmaceutical Industries
6.15.1 Sun Pharmaceutical Industries Corporation Information
6.15.2 Sun Pharmaceutical Industries Anti-Emetic Drug Description, Business Overview and Total Revenue
6.15.3 Sun Pharmaceutical Industries Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Sun Pharmaceutical Industries Products Offered
6.15.5 Sun Pharmaceutical Industries Recent Development
6.16 Teva Pharmaceutical
6.16.1 Teva Pharmaceutical Corporation Information
6.16.2 Teva Pharmaceutical Anti-Emetic Drug Description, Business Overview and Total Revenue
6.16.3 Teva Pharmaceutical Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Teva Pharmaceutical Products Offered
6.16.5 Teva Pharmaceutical Recent Development
6.17 Pfizer
6.17.1 Pfizer Corporation Information
6.17.2 Pfizer Anti-Emetic Drug Description, Business Overview and Total Revenue
6.17.3 Pfizer Anti-Emetic Drug Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Pfizer Products Offered
6.17.5 Pfizer Recent Development
7 ANTI-EMETIC DRUG MANUFACTURING COST ANALYSIS
7.1 Anti-Emetic Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-Emetic Drug
7.4 Anti-Emetic Drug Industrial Chain Analysis
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
8.1 Marketing Channel
8.2 Anti-Emetic Drug Distributors List
8.3 Anti-Emetic Drug Customers
9 MARKET DYNAMICS
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 GLOBAL MARKET FORECAST
10.1 Global Anti-Emetic Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-Emetic Drug by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Anti-Emetic Drug by Type (2021-2026)
10.2 Anti-Emetic Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-Emetic Drug by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Anti-Emetic Drug by Application (2021-2026)
10.3 Anti-Emetic Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-Emetic Drug by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Anti-Emetic Drug by Region (2021-2026)
10.4 North America Anti-Emetic Drug Estimates and Projections (2021-2026)
10.5 Europe Anti-Emetic Drug Estimates and Projections (2021-2026)
10.6 Asia Pacific Anti-Emetic Drug Estimates and Projections (2021-2026)
10.7 Latin America Anti-Emetic Drug Estimates and Projections (2021-2026)
10.8 Middle East and Africa Anti-Emetic Drug Estimates and Projections (2021-2026)
11 RESEARCH FINDING AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
LIST OF TABLES
Table 1. Global Anti-Emetic Drug Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Anti-Emetic Drug Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Anti-Emetic Drug Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. COVID-19 Impact Global Market: (Four Anti-Emetic Drug Market Size Forecast Scenarios)
Table 5. Opportunities and Trends for Anti-Emetic Drug Players in the COVID-19 Landscape
Table 6. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 7. Key Regions/Countries Measures against Covid-19 Impact
Table 8. Proposal for Anti-Emetic Drug Players to Combat Covid-19 Impact
Table 9. Global Key Anti-Emetic Drug Manufacturers Covered in This Study
Table 10. Global Anti-Emetic Drug Sales (K Units) by Manufacturers (2015-2020)
Table 11. Global Anti-Emetic Drug Sales Share by Manufacturers (2015-2020)
Table 12. Global Anti-Emetic Drug Revenue (Million USD) by Manufacturers (2015-2020)
Table 13. Global Anti-Emetic Drug Revenue Share by Manufacturers (2015-2020)
Table 14. Global Market Anti-Emetic Drug Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 15. Manufacturers Anti-Emetic Drug Sales Sites and Area Served
Table 16. Manufacturers Anti-Emetic Drug Product Types
Table 17. Global Anti-Emetic Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 18. Global Anti-Emetic Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Emetic Drug as of 2019)
Table 19.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 20. Main Points Interviewed from Key Anti-Emetic Drug Players
Table 21. Global Anti-Emetic Drug Sales (K Units) by Region (2015-2020)
Table 22. Global Anti-Emetic Drug Sales Market Share by Region (2015-2020)
Table 23. Global Anti-Emetic Drug Revenue (Million US$) by Region (2015-2020)
Table 24. Global Anti-Emetic Drug Revenue Market Share by Region (2015-2020)
Table 25. North America Anti-Emetic Drug Sales by Country (2015-2020) (K Units)
Table 26. North America Anti-Emetic Drug Sales Market Share by Country (2015-2020)
Table 27. North America Anti-Emetic Drug Revenue by Country (2015-2020) (US$ Million)
Table 28. North America Anti-Emetic Drug Revenue Market Share by Country (2015-2020)
Table 29. Europe Anti-Emetic Drug Sales by Country (2015-2020) (K Units)
Table 30. Europe Anti-Emetic Drug Sales Market Share by Country (2015-2020)
Table 31. Europe Anti-Emetic Drug Revenue by Country (2015-2020) (US$ Million)
Table 32. Europe Anti-Emetic Drug Revenue Market Share by Country (2015-2020)
Table 33. Asia Pacific Anti-Emetic Drug Sales by Region (2015-2020) (K Units)
Table 34. Asia Pacific Anti-Emetic Drug Sales Market Share by Region (2015-2020)
Table 35. Asia Pacific Anti-Emetic Drug Revenue by Region (2015-2020) (US$ Million)
Table 36. Asia Pacific Anti-Emetic Drug Revenue Market Share by Region (2015-2020)
Table 37. Latin America Anti-Emetic Drug Sales by Country (2015-2020) (K Units)
Table 38. Latin America Anti-Emetic Drug Sales Market Share by Country (2015-2020)
Table 39. Latin America Anti-Emetic Drug Revenue by Country (2015-2020) (US$ Million)
Table 40. Latin America Anti-Emetic Drug Revenue Market Share by Country (2015-2020)
Table 41. Middle East and Africa Anti-Emetic Drug Sales by Country (2015-2020) (K Units)
Table 42. Middle East and Africa Anti-Emetic Drug Sales Market Share by Country (2015-2020)
Table 43. Middle East and Africa Anti-Emetic Drug Revenue by Country (2015-2020) (US$ Million)
Table 44. Middle East and Africa Anti-Emetic Drug Revenue Market Share by Country (2015-2020)
Table 45. Global Anti-Emetic Drug Sales (K Units) by Type (2015-2020)
Table 46. Global Anti-Emetic Drug Sales Share by Type (2015-2020)
Table 47. Global Anti-Emetic Drug Revenue (Million US$) by Type (2015-2020)
Table 48. Global Anti-Emetic Drug Revenue Share by Type (2015-2020)
Table 49. Global Anti-Emetic Drug Price (US$/Unit) by Type (2015-2020)
Table 50. Global Anti-Emetic Drug Sales (K Units) by Application (2015-2020)
Table 51. Global Anti-Emetic Drug Sales Market Share by Application (2015-2020)
Table 52. Global Anti-Emetic Drug Sales Growth Rate by Application (2015-2020)
Table 53. Merck Anti-Emetic Drug Corporation Information
Table 54. Merck Description and Business Overview
Table 55. Merck Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. Merck Main Product
Table 57. Merck Recent Development
Table 58. Novartis Anti-Emetic Drug Corporation Information
Table 59. Novartis Corporation Information
Table 60. Novartis Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. Novartis Main Product
Table 62. Novartis Recent Development
Table 63. Glenmark Pharmaceuticals Anti-Emetic Drug Corporation Information
Table 64. Glenmark Pharmaceuticals Corporation Information
Table 65. Glenmark Pharmaceuticals Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Glenmark Pharmaceuticals Main Product
Table 67. Glenmark Pharmaceuticals Recent Development
Table 68. F. Hoffmann-La Roche Anti-Emetic Drug Corporation Information
Table 69. F. Hoffmann-La Roche Corporation Information
Table 70. F. Hoffmann-La Roche Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. F. Hoffmann-La Roche Main Product
Table 72. F. Hoffmann-La Roche Recent Development
Table 73. Heron Therapeutics Anti-Emetic Drug Corporation Information
Table 74. Heron Therapeutics Corporation Information
Table 75. Heron Therapeutics Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. Heron Therapeutics Main Product
Table 77. Heron Therapeutics Recent Development
Table 78. Kyowa Kirin Anti-Emetic Drug Corporation Information
Table 79. Kyowa Kirin Corporation Information
Table 80. Kyowa Kirin Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. Kyowa Kirin Main Product
Table 82. Kyowa Kirin Recent Development
Table 83. Aurobindo Pharma Anti-Emetic Drug Corporation Information
Table 84. Aurobindo Pharma Corporation Information
Table 85. Aurobindo Pharma Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. Aurobindo Pharma Main Product
Table 87. Aurobindo Pharma Recent Development
Table 88. Mylan Anti-Emetic Drug Corporation Information
Table 89. Mylan Corporation Information
Table 90. Mylan Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 91. Mylan Main Product
Table 92. Mylan Recent Development
Table 93. Hikma Anti-Emetic Drug Corporation Information
Table 94. Hikma Corporation Information
Table 95. Hikma Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 96. Hikma Main Product
Table 97. Hikma Recent Development
Table 98. Akorn Anti-Emetic Drug Corporation Information
Table 99. Akorn Corporation Information
Table 100. Akorn Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 101. Akorn Main Product
Table 102. Akorn Recent Development
Table 103. Dr. Reddy’s Laboratories Anti-Emetic Drug Corporation Information
Table 104. Dr. Reddy’s Laboratories Corporation Information
Table 105. Dr. Reddy’s Laboratories Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 106. Dr. Reddy’s Laboratories Main Product
Table 107. Dr. Reddy’s Laboratories Recent Development
Table 108. Cipla Anti-Emetic Drug Corporation Information
Table 109. Cipla Corporation Information
Table 110. Cipla Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 111. Cipla Main Product
Table 112. Cipla Recent Development
Table 113. Fresenius Kabi Anti-Emetic Drug Corporation Information
Table 114. Fresenius Kabi Corporation Information
Table 115. Fresenius Kabi Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 116. Fresenius Kabi Main Product
Table 117. Fresenius Kabi Recent Development
Table 118. Wockhardt Anti-Emetic Drug Corporation Information
Table 119. Wockhardt Corporation Information
Table 120. Wockhardt Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 121. Wockhardt Main Product
Table 122. Wockhardt Recent Development
Table 123. Sun Pharmaceutical Industries Anti-Emetic Drug Corporation Information
Table 124. Sun Pharmaceutical Industries Corporation Information
Table 125. Sun Pharmaceutical Industries Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 126. Sun Pharmaceutical Industries Main Product
Table 127. Sun Pharmaceutical Industries Recent Development
Table 128. Teva Pharmaceutical Anti-Emetic Drug Corporation Information
Table 129. Teva Pharmaceutical Corporation Information
Table 130. Teva Pharmaceutical Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 131. Teva Pharmaceutical Main Product
Table 132. Teva Pharmaceutical Recent Development
Table 133. Pfizer Anti-Emetic Drug Corporation Information
Table 134. Pfizer Corporation Information
Table 135. Pfizer Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 136. Pfizer Main Product
Table 137. Pfizer Recent Development
Table 138. Sales Base and Market Concentration Rate of Raw Material
Table 139. Key Suppliers of Raw Materials
Table 140. Anti-Emetic Drug Distributors List
Table 141. Anti-Emetic Drug Customers List
Table 142. Market Key Trends
Table 143. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 144. Key Challenges
Table 145. Global Anti-Emetic Drug Sales (K Units) Forecast by Type (2021-2026)
Table 146. Global Anti-Emetic Drug Sales Market Share Forecast by Type (2021-2026)
Table 147. Global Anti-Emetic Drug Revenue (Million US$) Forecast by Type (2021-2026)
Table 148. Global Anti-Emetic Drug Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 149. Global Anti-Emetic Drug Sales (K Units) Forecast by Application (2021-2026)
Table 150. Global Anti-Emetic Drug Revenue (Million US$) Forecast by Application (2021-2026)
Table 151. Global Anti-Emetic Drug Sales (K Units) Forecast by Region (2021-2026)
Table 152. Global Anti-Emetic Drug Sales Market Share Forecast by Region (2021-2026)
Table 153. Global Anti-Emetic Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 154. Global Anti-Emetic Drug Revenue Market Share Forecast by Region (2021-2026)
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
Table 1. Global Anti-Emetic Drug Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Anti-Emetic Drug Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Anti-Emetic Drug Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. COVID-19 Impact Global Market: (Four Anti-Emetic Drug Market Size Forecast Scenarios)
Table 5. Opportunities and Trends for Anti-Emetic Drug Players in the COVID-19 Landscape
Table 6. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 7. Key Regions/Countries Measures against Covid-19 Impact
Table 8. Proposal for Anti-Emetic Drug Players to Combat Covid-19 Impact
Table 9. Global Key Anti-Emetic Drug Manufacturers Covered in This Study
Table 10. Global Anti-Emetic Drug Sales (K Units) by Manufacturers (2015-2020)
Table 11. Global Anti-Emetic Drug Sales Share by Manufacturers (2015-2020)
Table 12. Global Anti-Emetic Drug Revenue (Million USD) by Manufacturers (2015-2020)
Table 13. Global Anti-Emetic Drug Revenue Share by Manufacturers (2015-2020)
Table 14. Global Market Anti-Emetic Drug Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 15. Manufacturers Anti-Emetic Drug Sales Sites and Area Served
Table 16. Manufacturers Anti-Emetic Drug Product Types
Table 17. Global Anti-Emetic Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 18. Global Anti-Emetic Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Emetic Drug as of 2019)
Table 19.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 20. Main Points Interviewed from Key Anti-Emetic Drug Players
Table 21. Global Anti-Emetic Drug Sales (K Units) by Region (2015-2020)
Table 22. Global Anti-Emetic Drug Sales Market Share by Region (2015-2020)
Table 23. Global Anti-Emetic Drug Revenue (Million US$) by Region (2015-2020)
Table 24. Global Anti-Emetic Drug Revenue Market Share by Region (2015-2020)
Table 25. North America Anti-Emetic Drug Sales by Country (2015-2020) (K Units)
Table 26. North America Anti-Emetic Drug Sales Market Share by Country (2015-2020)
Table 27. North America Anti-Emetic Drug Revenue by Country (2015-2020) (US$ Million)
Table 28. North America Anti-Emetic Drug Revenue Market Share by Country (2015-2020)
Table 29. Europe Anti-Emetic Drug Sales by Country (2015-2020) (K Units)
Table 30. Europe Anti-Emetic Drug Sales Market Share by Country (2015-2020)
Table 31. Europe Anti-Emetic Drug Revenue by Country (2015-2020) (US$ Million)
Table 32. Europe Anti-Emetic Drug Revenue Market Share by Country (2015-2020)
Table 33. Asia Pacific Anti-Emetic Drug Sales by Region (2015-2020) (K Units)
Table 34. Asia Pacific Anti-Emetic Drug Sales Market Share by Region (2015-2020)
Table 35. Asia Pacific Anti-Emetic Drug Revenue by Region (2015-2020) (US$ Million)
Table 36. Asia Pacific Anti-Emetic Drug Revenue Market Share by Region (2015-2020)
Table 37. Latin America Anti-Emetic Drug Sales by Country (2015-2020) (K Units)
Table 38. Latin America Anti-Emetic Drug Sales Market Share by Country (2015-2020)
Table 39. Latin America Anti-Emetic Drug Revenue by Country (2015-2020) (US$ Million)
Table 40. Latin America Anti-Emetic Drug Revenue Market Share by Country (2015-2020)
Table 41. Middle East and Africa Anti-Emetic Drug Sales by Country (2015-2020) (K Units)
Table 42. Middle East and Africa Anti-Emetic Drug Sales Market Share by Country (2015-2020)
Table 43. Middle East and Africa Anti-Emetic Drug Revenue by Country (2015-2020) (US$ Million)
Table 44. Middle East and Africa Anti-Emetic Drug Revenue Market Share by Country (2015-2020)
Table 45. Global Anti-Emetic Drug Sales (K Units) by Type (2015-2020)
Table 46. Global Anti-Emetic Drug Sales Share by Type (2015-2020)
Table 47. Global Anti-Emetic Drug Revenue (Million US$) by Type (2015-2020)
Table 48. Global Anti-Emetic Drug Revenue Share by Type (2015-2020)
Table 49. Global Anti-Emetic Drug Price (US$/Unit) by Type (2015-2020)
Table 50. Global Anti-Emetic Drug Sales (K Units) by Application (2015-2020)
Table 51. Global Anti-Emetic Drug Sales Market Share by Application (2015-2020)
Table 52. Global Anti-Emetic Drug Sales Growth Rate by Application (2015-2020)
Table 53. Merck Anti-Emetic Drug Corporation Information
Table 54. Merck Description and Business Overview
Table 55. Merck Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. Merck Main Product
Table 57. Merck Recent Development
Table 58. Novartis Anti-Emetic Drug Corporation Information
Table 59. Novartis Corporation Information
Table 60. Novartis Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. Novartis Main Product
Table 62. Novartis Recent Development
Table 63. Glenmark Pharmaceuticals Anti-Emetic Drug Corporation Information
Table 64. Glenmark Pharmaceuticals Corporation Information
Table 65. Glenmark Pharmaceuticals Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Glenmark Pharmaceuticals Main Product
Table 67. Glenmark Pharmaceuticals Recent Development
Table 68. F. Hoffmann-La Roche Anti-Emetic Drug Corporation Information
Table 69. F. Hoffmann-La Roche Corporation Information
Table 70. F. Hoffmann-La Roche Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. F. Hoffmann-La Roche Main Product
Table 72. F. Hoffmann-La Roche Recent Development
Table 73. Heron Therapeutics Anti-Emetic Drug Corporation Information
Table 74. Heron Therapeutics Corporation Information
Table 75. Heron Therapeutics Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. Heron Therapeutics Main Product
Table 77. Heron Therapeutics Recent Development
Table 78. Kyowa Kirin Anti-Emetic Drug Corporation Information
Table 79. Kyowa Kirin Corporation Information
Table 80. Kyowa Kirin Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. Kyowa Kirin Main Product
Table 82. Kyowa Kirin Recent Development
Table 83. Aurobindo Pharma Anti-Emetic Drug Corporation Information
Table 84. Aurobindo Pharma Corporation Information
Table 85. Aurobindo Pharma Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. Aurobindo Pharma Main Product
Table 87. Aurobindo Pharma Recent Development
Table 88. Mylan Anti-Emetic Drug Corporation Information
Table 89. Mylan Corporation Information
Table 90. Mylan Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 91. Mylan Main Product
Table 92. Mylan Recent Development
Table 93. Hikma Anti-Emetic Drug Corporation Information
Table 94. Hikma Corporation Information
Table 95. Hikma Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 96. Hikma Main Product
Table 97. Hikma Recent Development
Table 98. Akorn Anti-Emetic Drug Corporation Information
Table 99. Akorn Corporation Information
Table 100. Akorn Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 101. Akorn Main Product
Table 102. Akorn Recent Development
Table 103. Dr. Reddy’s Laboratories Anti-Emetic Drug Corporation Information
Table 104. Dr. Reddy’s Laboratories Corporation Information
Table 105. Dr. Reddy’s Laboratories Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 106. Dr. Reddy’s Laboratories Main Product
Table 107. Dr. Reddy’s Laboratories Recent Development
Table 108. Cipla Anti-Emetic Drug Corporation Information
Table 109. Cipla Corporation Information
Table 110. Cipla Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 111. Cipla Main Product
Table 112. Cipla Recent Development
Table 113. Fresenius Kabi Anti-Emetic Drug Corporation Information
Table 114. Fresenius Kabi Corporation Information
Table 115. Fresenius Kabi Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 116. Fresenius Kabi Main Product
Table 117. Fresenius Kabi Recent Development
Table 118. Wockhardt Anti-Emetic Drug Corporation Information
Table 119. Wockhardt Corporation Information
Table 120. Wockhardt Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 121. Wockhardt Main Product
Table 122. Wockhardt Recent Development
Table 123. Sun Pharmaceutical Industries Anti-Emetic Drug Corporation Information
Table 124. Sun Pharmaceutical Industries Corporation Information
Table 125. Sun Pharmaceutical Industries Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 126. Sun Pharmaceutical Industries Main Product
Table 127. Sun Pharmaceutical Industries Recent Development
Table 128. Teva Pharmaceutical Anti-Emetic Drug Corporation Information
Table 129. Teva Pharmaceutical Corporation Information
Table 130. Teva Pharmaceutical Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 131. Teva Pharmaceutical Main Product
Table 132. Teva Pharmaceutical Recent Development
Table 133. Pfizer Anti-Emetic Drug Corporation Information
Table 134. Pfizer Corporation Information
Table 135. Pfizer Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 136. Pfizer Main Product
Table 137. Pfizer Recent Development
Table 138. Sales Base and Market Concentration Rate of Raw Material
Table 139. Key Suppliers of Raw Materials
Table 140. Anti-Emetic Drug Distributors List
Table 141. Anti-Emetic Drug Customers List
Table 142. Market Key Trends
Table 143. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 144. Key Challenges
Table 145. Global Anti-Emetic Drug Sales (K Units) Forecast by Type (2021-2026)
Table 146. Global Anti-Emetic Drug Sales Market Share Forecast by Type (2021-2026)
Table 147. Global Anti-Emetic Drug Revenue (Million US$) Forecast by Type (2021-2026)
Table 148. Global Anti-Emetic Drug Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 149. Global Anti-Emetic Drug Sales (K Units) Forecast by Application (2021-2026)
Table 150. Global Anti-Emetic Drug Revenue (Million US$) Forecast by Application (2021-2026)
Table 151. Global Anti-Emetic Drug Sales (K Units) Forecast by Region (2021-2026)
Table 152. Global Anti-Emetic Drug Sales Market Share Forecast by Region (2021-2026)
Table 153. Global Anti-Emetic Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 154. Global Anti-Emetic Drug Revenue Market Share Forecast by Region (2021-2026)
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Picture of Anti-Emetic Drug
Figure 2. Global Anti-Emetic Drug Sales Market Share by Type: 2020 VS 2026
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. Others Product Picture
Figure 6. Global Anti-Emetic Drug Consumption Market Share by Application: 2020 VS 2026
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Home Care
Figure 10. Others
Figure 11. Global Anti-Emetic Drug Market Size 2015-2026 (US$ Million)
Figure 12. Global Anti-Emetic Drug Sales Capacity (K Units) (2015-2026)
Figure 13. Global Anti-Emetic Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Anti-Emetic Drug Sales Share by Manufacturers in 2020
Figure 15. Global Anti-Emetic Drug Revenue Share by Manufacturers in 2019
Figure 16. The Global 5 and 10 Largest Players: Market Share by Anti-Emetic Drug Revenue in 2019
Figure 17. Anti-Emetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Anti-Emetic Drug Sales Market Share by Region (2015-2020)
Figure 19. Global Anti-Emetic Drug Sales Market Share by Region in 2019
Figure 20. Global Anti-Emetic Drug Revenue Market Share by Region (2015-2020)
Figure 21. Global Anti-Emetic Drug Revenue Market Share by Region in 2019
Figure 22. North America Anti-Emetic Drug Sales Market Share by Country in 2019
Figure 23. North America Anti-Emetic Drug Revenue Market Share by Country in 2019
Figure 24. U.S. Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 25. U.S. Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Canada Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 27. Canada Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Europe Anti-Emetic Drug Sales Market Share by Country in 2019
Figure 29. Europe Anti-Emetic Drug Revenue Market Share by Country in 2019
Figure 30. Germany Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 31. Germany Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. France Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 33. France Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. U.K. Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.K. Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Italy Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 37. Italy Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Russia Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 39. Russia Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Asia Pacific Anti-Emetic Drug Sales Market Share by Region in 2019
Figure 41. Asia Pacific Anti-Emetic Drug Revenue Market Share by Region in 2019
Figure 42. China Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 43. China Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Japan Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 45. Japan Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. South Korea Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 47. South Korea Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. India Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 49. India Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Australia Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 51. Australia Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Taiwan Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 53. Taiwan Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Indonesia Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 55. Indonesia Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Thailand Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 57. Thailand Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Malaysia Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 59. Malaysia Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Philippines Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 61. Philippines Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Vietnam Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 63. Vietnam Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Latin America Anti-Emetic Drug Sales Market Share by Country in 2019
Figure 65. Latin America Anti-Emetic Drug Revenue Market Share by Country in 2019
Figure 66. Mexico Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 67. Mexico Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Brazil Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 69. Brazil Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Argentina Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Middle East and Africa Anti-Emetic Drug Sales Market Share by Country in 2019
Figure 73. Middle East and Africa Anti-Emetic Drug Revenue Market Share by Country in 2019
Figure 74. Turkey Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 75. Turkey Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Saudi Arabia Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 77. Saudi Arabia Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. UAE Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 79. UAE Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Sales Market Share of Anti-Emetic Drug by Type (2015-2020)
Figure 81. Sales Market Share of Anti-Emetic Drug by Type in 2019
Figure 82. Revenue Share of Anti-Emetic Drug by Type (2015-2020)
Figure 83. Revenue Market Share of Anti-Emetic Drug by Type in 2019
Figure 84. Global Anti-Emetic Drug Sales Growth by Type (2015-2020) (K Units)
Figure 85. Global Anti-Emetic Drug Sales Market Share by Application (2015-2020)
Figure 86. Global Anti-Emetic Drug Sales Market Share by Application in 2019
Figure 87. Global Revenue Share of Anti-Emetic Drug by Application (2015-2020)
Figure 88. Global Revenue Share of Anti-Emetic Drug by Application in 2020
Figure 89. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Glenmark Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Heron Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Kyowa Kirin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Hikma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Akorn Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Dr. Reddy’s Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Fresenius Kabi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Wockhardt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Sun Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 105. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 106. Price Trend of Key Raw Materials
Figure 107. Manufacturing Cost Structure of Anti-Emetic Drug
Figure 108. Manufacturing Process Analysis of Anti-Emetic Drug
Figure 109. Anti-Emetic Drug Industrial Chain Analysis
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Porter's Five Forces Analysis
Figure 113. North America Anti-Emetic Drug Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 114. North America Anti-Emetic Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Europe Anti-Emetic Drug Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 116. Europe Anti-Emetic Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Latin America Anti-Emetic Drug Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 118. Latin America Anti-Emetic Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 119. Middle East and Africa Anti-Emetic Drug Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 120. Middle East and Africa Anti-Emetic Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 121. Asia Pacific Anti-Emetic Drug Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 122. Asia Pacific Anti-Emetic Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
Figure 1. Picture of Anti-Emetic Drug
Figure 2. Global Anti-Emetic Drug Sales Market Share by Type: 2020 VS 2026
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. Others Product Picture
Figure 6. Global Anti-Emetic Drug Consumption Market Share by Application: 2020 VS 2026
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Home Care
Figure 10. Others
Figure 11. Global Anti-Emetic Drug Market Size 2015-2026 (US$ Million)
Figure 12. Global Anti-Emetic Drug Sales Capacity (K Units) (2015-2026)
Figure 13. Global Anti-Emetic Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Anti-Emetic Drug Sales Share by Manufacturers in 2020
Figure 15. Global Anti-Emetic Drug Revenue Share by Manufacturers in 2019
Figure 16. The Global 5 and 10 Largest Players: Market Share by Anti-Emetic Drug Revenue in 2019
Figure 17. Anti-Emetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Anti-Emetic Drug Sales Market Share by Region (2015-2020)
Figure 19. Global Anti-Emetic Drug Sales Market Share by Region in 2019
Figure 20. Global Anti-Emetic Drug Revenue Market Share by Region (2015-2020)
Figure 21. Global Anti-Emetic Drug Revenue Market Share by Region in 2019
Figure 22. North America Anti-Emetic Drug Sales Market Share by Country in 2019
Figure 23. North America Anti-Emetic Drug Revenue Market Share by Country in 2019
Figure 24. U.S. Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 25. U.S. Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Canada Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 27. Canada Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Europe Anti-Emetic Drug Sales Market Share by Country in 2019
Figure 29. Europe Anti-Emetic Drug Revenue Market Share by Country in 2019
Figure 30. Germany Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 31. Germany Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. France Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 33. France Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. U.K. Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.K. Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Italy Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 37. Italy Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Russia Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 39. Russia Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Asia Pacific Anti-Emetic Drug Sales Market Share by Region in 2019
Figure 41. Asia Pacific Anti-Emetic Drug Revenue Market Share by Region in 2019
Figure 42. China Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 43. China Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Japan Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 45. Japan Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. South Korea Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 47. South Korea Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. India Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 49. India Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Australia Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 51. Australia Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Taiwan Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 53. Taiwan Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Indonesia Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 55. Indonesia Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Thailand Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 57. Thailand Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Malaysia Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 59. Malaysia Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Philippines Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 61. Philippines Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Vietnam Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 63. Vietnam Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Latin America Anti-Emetic Drug Sales Market Share by Country in 2019
Figure 65. Latin America Anti-Emetic Drug Revenue Market Share by Country in 2019
Figure 66. Mexico Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 67. Mexico Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Brazil Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 69. Brazil Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Argentina Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Middle East and Africa Anti-Emetic Drug Sales Market Share by Country in 2019
Figure 73. Middle East and Africa Anti-Emetic Drug Revenue Market Share by Country in 2019
Figure 74. Turkey Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 75. Turkey Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Saudi Arabia Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 77. Saudi Arabia Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. UAE Anti-Emetic Drug Sales Growth Rate (2015-2020) (K Units)
Figure 79. UAE Anti-Emetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Sales Market Share of Anti-Emetic Drug by Type (2015-2020)
Figure 81. Sales Market Share of Anti-Emetic Drug by Type in 2019
Figure 82. Revenue Share of Anti-Emetic Drug by Type (2015-2020)
Figure 83. Revenue Market Share of Anti-Emetic Drug by Type in 2019
Figure 84. Global Anti-Emetic Drug Sales Growth by Type (2015-2020) (K Units)
Figure 85. Global Anti-Emetic Drug Sales Market Share by Application (2015-2020)
Figure 86. Global Anti-Emetic Drug Sales Market Share by Application in 2019
Figure 87. Global Revenue Share of Anti-Emetic Drug by Application (2015-2020)
Figure 88. Global Revenue Share of Anti-Emetic Drug by Application in 2020
Figure 89. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Glenmark Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Heron Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Kyowa Kirin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Hikma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Akorn Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Dr. Reddy’s Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Fresenius Kabi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Wockhardt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Sun Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 105. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 106. Price Trend of Key Raw Materials
Figure 107. Manufacturing Cost Structure of Anti-Emetic Drug
Figure 108. Manufacturing Process Analysis of Anti-Emetic Drug
Figure 109. Anti-Emetic Drug Industrial Chain Analysis
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Porter's Five Forces Analysis
Figure 113. North America Anti-Emetic Drug Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 114. North America Anti-Emetic Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Europe Anti-Emetic Drug Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 116. Europe Anti-Emetic Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Latin America Anti-Emetic Drug Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 118. Latin America Anti-Emetic Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 119. Middle East and Africa Anti-Emetic Drug Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 120. Middle East and Africa Anti-Emetic Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 121. Asia Pacific Anti-Emetic Drug Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 122. Asia Pacific Anti-Emetic Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
